Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol-Myers

Executive Summary

Robert Nowinski, PhD, to VP-new technology. Science & Technology Group. He continues as a corporate VP and president of subsidiary Genetic Systems. Nowinski was a founder of Genetic Systems, acquired by Bristol in 1986; Marvin Gorman, PhD, to exec VP of biotech research subsidiary Oncogen; Charles Heimbold, president of B-M's Health Care (non-pharmaceutical) Group, will assume corporate responsibility for planning and development, succeeding John Melton, who has resigned.

You may also be interested in...



US Rep. Pallone Demands Answers From FDA On Seeming Hair-Smoothing Formaldehyde Ban ‘Reversal’

Internal FDA emails obtained by the Environmental Working Group through a FOIA request indicate that the agency was moving toward rulemaking in 2016 to restrict or prohibit use of formaldehyde in heated hair-straightening cosmetics, but seemingly abandoned the initiative. That has Congress, NGOs and other stakeholders asking questions and renewing calls for cosmetics regulatory reform.

The Golden Winged Warbler And Creating Pharma Supply Chain Immunity

Expert outlines how pharma can create resilient and secure supply chains and some benefits of localization.

Bumpy Japan Zolgensma Review Holds Lessons For Applicants

Product review report reveals multiple delays and missteps on route to market, holding valuable lessons for other gene therapy developers but also evidencing an ultimately welcoming environment.

UsernamePublicRestriction

Register

OM011995

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel